Beta zero thalassemia caused by a base substitution that creates an alternative splice acceptor site in an intron.

A thalassemic beta‐globin gene cloned from a haplotype I chromosome contains a T to G transversion at position 116 of IVS1 which results in the generation of an abnormal alternative acceptor splice site. Transient expression studies revealed a 4‐fold decrease in the amount of RNA produced with greater than 99% of it being abnormally spliced despite preservation of the normal acceptor splice site at position 130. These results suggest that the mutation at IVS1 position 116 results in beta zero thalassemia. A closely related mutation at position 110 of IVS1 also generates a novel acceptor site and results in a similar decrease in total mRNA produced, but approximately 20% of the mRNA produced is normally spliced and thus the phenotype is that of beta + thalassemia. These observations suggest that short range position effects may play a dramatic role in the choice of potential splice acceptor sites. We demonstrate the presence of abnormally spliced mRNA in reticulocytes of affected individuals and show the mutation at IVS1 position 116 segregating from the mutation at IVS1 position 110 in a three generation pedigree. The mutation results in the creation of a MaeI restriction site, as do a number of other thalassemic mutations, and we demonstrate some difficulties that may arise in the differential diagnosis of these mutations.

[1]  G. Atweh,et al.  Identification of a beta-thalassemia mutation associated with a novel haplotype of RFLPs. , 1986, American journal of human genetics.

[2]  David Frendewey,et al.  Stepwise assembly of a pre-mRNA splicing complex requires U-snRNPs and specific intron sequences , 1985, Cell.

[3]  Phillip A. Sharp,et al.  A multicomponent complex is involved in the splicing of messenger RNA precursors , 1985, Cell.

[4]  R. Spritz,et al.  Deletion Analysis of the Human γ‐Globin IVS2: Sequence Requirements for RNA Splicing , 1985 .

[5]  D. Weatherall,et al.  DIRECT DETECTION OF β°39 THALASSAEMIC MUTATION WITH Mae 1 , 1985, The Lancet.

[6]  Tom Maniatis,et al.  Intron sequences involved in lariat formation during pre-mRNA splicing , 1985, Cell.

[7]  F. Collins,et al.  A point mutation in the Aγ-globin gene promoter in Greek hereditary persistence of fetal haemoglobin , 1985, Nature.

[8]  P. Sharp,et al.  Lariat RNA's as intermediates and products in the splicing of messenger RNA precursors. , 1984, Science.

[9]  F. Collins,et al.  G gamma beta+ hereditary persistence of fetal hemoglobin: cosmid cloning and identification of a specific mutation 5' to the G gamma gene. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Michael R. Green,et al.  Excision of an intact intron as a novel lariat structure during pre-mRNA splicing in vitro , 1984, Cell.

[11]  S. Orkin,et al.  Quantification of the close association between DNA haplotypes and specific β-thalassaemia mutations in Mediterraneans , 1984, Nature.

[12]  B. Wieringa,et al.  A minimal intron length but no specific internal sequence is required for splicing the large rabbit β-globin intron , 1984, Cell.

[13]  K. Takeshita,et al.  Intranuclear defect in beta-globin mRNA accumulation due to a premature translation termination codon. , 1984, Blood.

[14]  H. Bunn,et al.  Hemoglobin: Molecular, Genetic and Clinical Aspects , 1984 .

[15]  P. Sharp,et al.  Messenger RNA splicing in vitro: An excised intervening sequence and a potential intermediate , 1984, Cell.

[16]  T. Ley,et al.  Advances in thalassemia research. , 1984, Blood.

[17]  F. Laue,et al.  Three new restriction endonucleases MaeI, MaeII and MaeIII from Methanococcus aeolicus. , 1984, Nucleic acids research.

[18]  F. Collins,et al.  The molecular genetics of human hemoglobin. , 1984, Progress in nucleic acid research and molecular biology.

[19]  S. Orkin,et al.  The mutation and polymorphism of the human beta-globin gene and its surrounding DNA. , 1984, Annual review of genetics.

[20]  R. Spritz,et al.  RNA splice site selection: evidence for a 5' leads to 3' scanning model. , 1983, Science.

[21]  J. Reiser,et al.  Evidence against a scanning model of RNA splicing. , 1983, The EMBO journal.

[22]  Tom Maniatis,et al.  Specific transcription and RNA splicing defects in five cloned β-thalassaemia genes , 1983, Nature.

[23]  Charles Weissmann,et al.  Unusual splice sites revealed by mutagenic inactivation of an authentic splice site of the rabbit β-globin gene , 1983, Nature.

[24]  A. Place,et al.  Deletions at intervening sequence splice sites in the alcohol dehydrogenase gene of Drosophila. , 1982, Nucleic acids research.

[25]  T. Ley,et al.  Differences in human α-, β- and δ-globin gene expression in monkey kidney cells , 1982, Cell.

[26]  Stuart H. Orkin,et al.  Abnormal RNA splicing causes one form of α thalassemia , 1982, Cell.

[27]  Tom Maniatis,et al.  A single-base change at a splice site in a β0-thalassemic gene causes abnormal RNA splicing , 1982, Cell.

[28]  S. Orkin,et al.  Linkage of β-thalassaemia mutations and β-globin gene polymorphisms with DNA polymorphisms in human β-globin gene cluster , 1982, Nature.

[29]  S. Weissman,et al.  Abnormally spliced messenger RNA in erythroid cells from patients with β + thalassemia and monkey cells expressing a cloned β +-thalassemic gene , 1982, Cell.

[30]  Craig Montell,et al.  Resolving the functions of overlapping viral genes by site-specific mutagenesis at a mRNA splice site , 1982, Nature.

[31]  Stephen M. Mount,et al.  A catalogue of splice junction sequences. , 1982, Nucleic acids research.

[32]  B. Forget,et al.  Defective processing of beta mRNA in different forms of beta +-thalassemia. , 1982, Transactions of the Association of American Physicians.

[33]  R. Flavell,et al.  β + Thalassemia: Aberrant splicing results from a single point mutation in an intron , 1981, Cell.

[34]  David Solnick,et al.  An adenovirus mutant defective in splicing RNA from early region 1A , 1981, Nature.

[35]  D. Westaway,et al.  An intron nucleotide sequence variant in a cloned β+-thalassaemia globin gene , 1981 .

[36]  P. A. Biro,et al.  Base substitution in an intervening sequence of a beta+-thalassemic human globin gene. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[37]  P. Sharp.  Speculations on RNA splicing , 1981, Cell.

[38]  R. Wall,et al.  A mechanism for RNA splicing. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Stephen M. Mount,et al.  Are snRNPs involved in splicing? , 1980, Nature.

[40]  M. Takanami.  [56] RNA polymerase nascent product analysis , 1980 .

[41]  R. Treisman,et al.  Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping. , 1980, Methods in enzymology.

[42]  G. Khoury,et al.  BKV splice sequences based on analysis of preferred donor and acceptor sites. , 1979, Nucleic acids research.

[43]  Tom Maniatis,et al.  Transformation of mammalian cells with genes from procaryotes and eucaryotes , 1979, Cell.

[44]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[45]  P. Sharp,et al.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids , 1977, Cell.

[46]  E. Southern.  Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.

[47]  B. Forget,et al.  Defect in messenger RNA for human hemoglobin synthesis in beta thalassemia. , 1971, The Journal of clinical investigation.

[48]  Y. Kan,et al.  Mild thalassemia: the result of interactions of alpha and beta thalassemia genes. , 1970, The Journal of clinical investigation.